Tilray Brands Inc (TLRY) Stock Price, Quote & News

Company Profile

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 844 845 7291

Website: www.tilray.com

Address:

265 Talbot Street West, Leamington, Canada

Stock_Catcher Jan. 14 at 2:43 AM

Wealthy Wednesday Watchlist Pt. 3 $LUNR $SOFI $TLRY $BBAI $PLUG Let's Find another 950% Runner

0 · Reply

DipNrip75 Jan. 14 at 2:35 AM

$TLRY What Is Wall Street Saying About TLRY Stock? Wall Street expects the stock to rally 56% from current levels based on the average target price of $15.21. Plus, the Street-high estimate of $23 indicates the stock could rise as high as 135% in the next 12 months. https://www.barchart.com/story/news/37015115/this-under-10-growth-stock-may-be-better-positioned-than-investors-realize

0 · Reply

TomTomccc Jan. 14 at 2:20 AM

$TLRY This piece of trash can't even gain 1% a day. It’s just a non-stop cycle of pump and dump, while IREN is out here consistently pumping 7% every single day.

0 · Reply

TomTomccc Jan. 14 at 2:08 AM

$TLRY pump and dump every day

0 · Reply

LegendaryDeemo Jan. 14 at 1:23 AM

Early entries on small-cap rockets aren’t luck — @ReversalFox is a good one to FolloW. Cashed in on plenty of his calls. 💎🔥 Runs comin up on $SNDL $TLRY $ALT $IBRX

0 · Reply

MtDave Jan. 14 at 1:21 AM

$TLRY pow boy sez a death cross is forming and it could be the bottom hehe irwin is going to q the bulls

0 · Reply

Digitalization2026 Jan. 14 at 12:44 AM

$AKAN $SMX $TLRY $AMT $CCI $AKAN Market Cap & Setup 📊🚀 $AKAN trading below $2 gives it a tiny market cap vs similar telecom/infrastructure peers. Even small tower/fiber companies often trade at $20–$100M+ once recurring revenue is visible. If AKAN begins monetizing assets, today’s price could look compressed. Short Interest & Float ⚡ • Short interest 100%+ • Very few shares left to borrow • Thin liquidity = fast moves Why it matters 🔥 We’ve seen single candles swing 50–100% in low float names. When supply is tight and shorts cover, moves can be sharp. Price Targets 🎯 (speculative) • Base reclaim: $3–$5 • Momentum build: $8–$12 🚀 • Strong rerate on real execution: $15–$25+ 🔥 Watch This Week / Next 👀 • Support: $1.80–2.00 • Reclaim: $2.20–2.40 • Volume spikes & big prints • Borrow cost/availability changes • Telecom execution or filing updates Manage risk, size appropriately, and watch catalysts closely.

0 · Reply

JasDehradun Jan. 14 at 12:29 AM

$TLRY Holding well for the last 2 sessions. I hope bottom is reached and up and up trend from here, 13 to 15 to 20 by end of January. Stay strong friends.

1 · Reply

POWGroup Jan. 14 at 12:19 AM

Tilray Brands Death Cross Forming... Could This Be The Bottom Signal? #TilrayBrands, #Tilray, #TLRY, $TLRY https://youtu.be/UJR9uEZOdrM

0 · Reply

macrossluvsrobotech Jan. 14 at 12:18 AM

$SNDL Dumb ass shorts posting dumb shit, one little bible thumper study, & he thinks it nullifies an Executive order, no son... your stupid... @Slickerthanall187, and the dumbass puts, shorts shares borrowed, or sold calls... also stupid, every day that passes brings us closer to class 3, super smart guy. ALL THE STUDIES A BREAK DOWN OF OVER 250 STUIDIES , I just posted 1 of them below, the breast cancer 1 , SEE SCREEN SHOT = "2025 Cannabis Research: A Breakdown of Over 250 Studies" "The pace of cannabis research in 2025 has been unprecedented. Through the end of August, scientists around the world have released hundreds of peer-reviewed studies exploring nearly every facet of the plant and its compounds." https://themarijuanaherald.com/2025/08/2025-cannabis-research-a-breakdown-of-over-250-studies/ CATCHING THE WHITE HOUSES ATTENTION, TO RESCHEDULE IT TO CLASS 3 = https://www.whitehouse.gov/presidential-actions/2025/12/increasing-medical-marijuana-and-cannabidiol-research/ FDA PENDING APPROVAL OF PSILOCYBIN TREATMENT FOR VETERANS AND OTHER NEURO DIVERGENT SUFFERING INDIVIDUALS IS ONE EXAMPLE . https://youtu.be/4V7C_bdsu1Q?si=c3DLCfr911aYdoYe $IBB $BIB $TLRY $JNJ

0 · Reply